From The Source

CSL Seqirus inks massive fluvax deal with UK government

2 minute read

Members Pharma/Biotech

By

Staff Writers

The company will manufacture five million doses of avian flu vaccine in the first quarter of 2025 at its UK plant.

The company will manufacture five million doses of avian flu vaccine in the first quarter of 2025 at its UK plant.

This content is for Health Services Daily subscribers only.
or Join Now.

End of content

No more pages to load

Log In Register ×